You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Analog insulin

Showing 1 - 25 of 9,662
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hyperglycemia, Stroke, Acute Trial in Dhaka (Analog Insulin, Human insulin)

Completed
Has Results
  • Hyperglycemia
  • Stroke, Acute
  • Analog Insulin
  • Human insulin
  • Dhaka, Bangladesh
    National Institute of Neurosciences and Hospital
Nov 5, 2021

Diabetes, Type 1 Trial (Afrezza, insulin degludec, Rapid-acting Insulin Analog)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Afrezza
  • +3 more
  • (no location specified)
Jun 6, 2023

Diabetes, Pregnancy Complications Trial in Copenhagen (Faster-acting Aspart insulin Fiasp, Control (insulin Novorapid))

Active, not recruiting
  • Diabetes Mellitus
  • Pregnancy Complications
  • Faster-acting Aspart insulin Fiasp
  • Control (insulin Novorapid)
  • Copenhagen, Denmark
    Center for Pregnant Women with Diabetes, Rigshospitalet
Oct 25, 2022

Type1diabetes Trial in New Haven (Quick Bolus, Standard Bolus)

Recruiting
  • Type1diabetes
  • Quick Bolus
  • Standard Bolus
  • New Haven, Connecticut
    Yale University
Jan 7, 2022

Quality of Life Trial in Besançon (Exenatide, Insulin)

Completed
  • Quality of Life
  • Besançon, France
    Post operative intensive care unit of the cardiac surgery depart
Mar 5, 2021

Four Second Line Pharmacological Strategies in Type 2 Diabetes

Active, not recruiting
  • Cardiovascular Events
  • +2 more
  • SGLT2 inhibitor
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 17, 2022

Diabetes, Type 2 Trial in Brampton, Etobicoke, Toronto (Basal insulin glargine and lixisenatide, Basal insulin Basaglar/Lantus +

Completed
  • Diabetes Mellitus, Type 2
  • Basal insulin glargine and lixisenatide
  • +2 more
  • Brampton, Ontario, Canada
  • +2 more
Feb 24, 2021

Switch From U-100 Insulin Analog to U-500 Regular Insulin in

Completed
  • Glucose Control in Patients With Type 2 Diabetes Mellitus Treated by U-500 Insulin Administered by a Pump Device
    • (no location specified)
    Apr 30, 2020

    Type 1 Diabetes Trial in China (LY2963016, Lantus®, Insulin Lispro)

    Completed
    Has Results
    • Type 1 Diabetes
    • Beijing, Beijing, China
    • +19 more
    Mar 3, 2021

    Type 2 Diabetes Trial in China (Insulin Analog Mid Mixture, Basal Insulin Analog)

    Completed
    Has Results
    • Type 2 Diabetes Mellitus
    • Insulin Analog Mid Mixture
    • Basal Insulin Analog
    • Beijing, Beijing, China
    • +31 more
    Mar 6, 2020

    Type 1 Diabetes, Lipoatrophy Trial (Apidra, current insulin)

    Completed
    • Type 1 Diabetes
    • Lipoatrophy
    • (no location specified)
    Oct 18, 2019

    Type 2 Diabetes Trial in China (LY2963016, Lantus®)

    Completed
    Has Results
    • Type 2 Diabetes
    • Hefei, Anhui, China
    • +31 more
    May 3, 2021

    To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children Trial in

    Completed
    • To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children
    • Glargine and regular insulin versus NPH and regular insulin
    • Lahore, Punjab, Pakistan
      Pediatric endocrine and diabetes section, Pediatric department,
    Jan 29, 2023

    Obesity, Pre Diabetes, Diabetes, Type 2 Trial in Hattiesburg (Ketone Ester Supplement, Placebo)

    Recruiting
    • Obesity
    • +3 more
    • Ketone Ester Supplement
    • Placebo
    • Hattiesburg, Mississippi
      University of Southern Mississippi - School of Kinesiology and N
    Dec 6, 2022

    Postprandial Hyperglycemia Trial (vegetable and protein first followed by carbohydrates (VPF) meal sequence)

    Not yet recruiting
    • Postprandial Hyperglycemia
    • vegetable and protein first followed by carbohydrates (VPF) meal sequence
    • (no location specified)
    May 29, 2023

    Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)

    Recruiting
    • Diabetes Mellitus, Type 2 Treated With Insulin
    • insulin degludec + liraglutide
    • Insulin Glargine - Insulin Aspart
    • Bogotá, Colombia
      Hospital Universitario San Ignacio
    Mar 2, 2023

    Nutrition, Healthy Trial (GCE + Low ALA, GCE + High ALA, Placebo)

    Not yet recruiting
    • Nutrition, Healthy
    • GCE + Low ALA
    • +2 more
    • (no location specified)
    Nov 7, 2023

    Healthy, Prediabetic State Trial in Esslingen (Collagen hydrolysate, Placebo)

    Not yet recruiting
    • Healthy
    • Prediabetic State
    • Collagen hydrolysate
    • Placebo
    • Esslingen, Germany
      BioTeSys GmbH
    May 24, 2023

    Polycystic Ovary Syndrome Trial in Shanghai (GLP-1 RAs, calorie restricted diet)

    Completed
    • Polycystic Ovary Syndrome
    • GLP-1 RAs
    • calorie restricted diet
    • Shanghai, Shanghai, China
      Shanghai Tenth People' Hospital
    Aug 2, 2022

    Type2 Diabetes Trial in India (Glargine + Glulisine, Premixed analogue insulin (70/30))

    Completed
    • Type2 Diabetes
    • Glargine + Glulisine
    • Premixed analogue insulin (70/30)
    • Belgaum, Karnataka, India
    • +7 more
    Sep 9, 2019

    Diabetes, Type 1 Trial in Nice (enhanced care model provided by Timkl, a home support provider)

    Recruiting
    • Diabetes Mellitus, Type 1
    • enhanced care model provided by Timkl, a home support provider
    • Nice, Paca, France
      CHU Nice - Hôpital l'Archet 2
    Sep 18, 2023

    Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,

    Completed
    Has Results
    • Prostate Adenocarcinoma
    • +4 more
    • Abiraterone Acetate
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 14, 2022

    Type 1 Diabetes Trial in Worldwide (Insulin glargine, 300 U/ml, Insulin degludec, 100U/ml, Background therapy: Rapid acting

    Completed
    Has Results
    • Type 1 Diabetes Mellitus
    • Insulin glargine, 300 U/ml
    • +2 more
    • Dallas, Texas
    • +6 more
    Oct 19, 2022

    Type1diabetes Trial in Renton (CGMIS (Continuous Glucose Monitoring Infusion Set))

    Recruiting
    • Type1diabetes
    • CGMIS (Continuous Glucose Monitoring Infusion Set)
    • Renton, Washington
      Rainier Clinical Research Center
    Sep 28, 2022

    Gestational Diabetes Trial in Boston (Meal A, Meal B)

    Recruiting
    • Gestational Diabetes
    • Meal A
    • Meal B
    • Boston, Massachusetts
    • +1 more
    May 7, 2022